These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37942534)

  • 1. Detection and clinical significance of CEACAM5 methylation in colorectal cancer patients.
    Huang SC; Chang SC; Liao TT; Yang MH
    Cancer Sci; 2024 Jan; 115(1):270-282. PubMed ID: 37942534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis.
    Li Q; Li Y; Li J; Ma Y; Dai W; Mo S; Xu Y; Li X; Cai S
    Int J Biol Sci; 2018; 14(7):726-735. PubMed ID: 29910683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
    Li DJ; Feng ZC; Li XR; Hu G
    World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.
    Gu S; Zaidi S; Hassan MI; Mohammad T; Malta TM; Noushmehr H; Nguyen B; Crandall KA; Srivastav J; Obias V; Lin P; Nguyen BN; Yao M; Yao R; King CH; Mazumder R; Mishra B; Rao S; Mishra L
    Gastroenterology; 2020 Jan; 158(1):238-252. PubMed ID: 31585122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway.
    Graule J; Uth K; Fischer E; Centeno I; Galván JA; Eichmann M; Rau TT; Langer R; Dawson H; Nitsche U; Traeger P; Berger MD; Schnüriger B; Hädrich M; Studer P; Inderbitzin D; Lugli A; Tschan MP; Zlobec I
    Clin Epigenetics; 2018 Sep; 10(1):120. PubMed ID: 30257705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells.
    Abdul-Wahid A; Cydzik M; Fischer NW; Prodeus A; Shively JE; Martel A; Alminawi S; Ghorab Z; Berinstein NL; Gariépy J
    Int J Cancer; 2018 Oct; 143(8):1963-1977. PubMed ID: 29756328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of serum/glucocorticoid regulated kinase 1 in colorectal tumours is largely independent of promoter hypermethylation.
    Lessi F; Beggs A; de Palo M; Anti M; Macarone Palmieri R; Francesconi S; Gomes V; Bevilacqua G; Tomlinson I; Segditsas S
    PLoS One; 2010 Nov; 5(11):e13840. PubMed ID: 21079778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin modulates DNA methylation in colorectal cancer cells.
    Link A; Balaguer F; Shen Y; Lozano JJ; Leung HC; Boland CR; Goel A
    PLoS One; 2013; 8(2):e57709. PubMed ID: 23460897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
    Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
    Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel protein isoforms of carcinoembryonic antigen are secreted from pancreatic, gastric and colorectal cancer cells.
    Hatakeyama K; Wakabayashi-Nakao K; Ohshima K; Sakura N; Yamaguchi K; Mochizuki T
    BMC Res Notes; 2013 Sep; 6():381. PubMed ID: 24070190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation.
    Tae CH; Ryu KJ; Kim SH; Kim HC; Chun HK; Min BH; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH
    BMC Cancer; 2013 Mar; 13():142. PubMed ID: 23517143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
    Kordowski F; Kolarova J; Schafmayer C; Buch S; Goldmann T; Marwitz S; Kugler C; Scheufele S; Gassling V; Németh CG; Brosch M; Hampe J; Lucius R; Röder C; Kalthoff H; Siebert R; Ammerpohl O; Reiss K
    BMC Cancer; 2018 Aug; 18(1):796. PubMed ID: 30081852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
    Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
    J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
    Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
    Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
    Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
    Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
    Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.